Navigation Links
BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
Date:12/7/2009

ut PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include (1) SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine, (2) Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection, (3) Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents, (4) RypVax(TM) - a recombinant dual antigen vaccine for plague, and (5) a third generation rPA anthrax vaccine.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) unde
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vivakor Announces Additions to Board of Directors and Scientific Advisory Board
2. ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis
3. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
4. BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
5. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
6. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
7. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
8. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
9. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
10. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
11. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 18, 2014  Neogen Corporation (Nasdaq: NEOG ... chief operating officer and president, has resigned, effective July ... a consultant going forward on special projects. His resignation ... in this position since September 2013. On an interim ... Herbert , who has been Neogen,s chief executive officer ...
(Date:7/18/2014)... (PRWEB) July 18, 2014 Reflecting the importance ... past ten years, Connie Rankin, the founder and president ... affiliate, recently introduced a fresh new approach to the ... for a Broker to influence the success of his or ... years. CRES was one of the first in this market ...
(Date:7/18/2014)... Nuclear Power Countries - Market Forecast, Key Companies and ... report from GlobalData, Emerging Nuclear Power Countries - Market ... the emerging nuclear market and the key factors affecting ... players and their global market share. The market value ... has also been estimated. , To browse a full ...
(Date:7/18/2014)... Switzerland , July 18, 2014 ... Education in Animal Research for the third consecutive year. ... State University, will attend a 1-week course at Zürich ... of the 3Rs (Replace, Reduce, Refine). As head of ... Popov has been given the task of adapting experimental ...
Breaking Biology Technology:LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused ... Yin, Chairman, President and CEO, is scheduled to ... Management Summit,Conference, at Grant Hyatt Beijing Hotel in ... 11th at 1:35 p.m., About Sinovac, ...
... realize the electrical units of voltage, resistance and ... are nowadays used. Important prerequisites are extremely pure ... crystal without collision with residual impurities. To be ... has set up a new molecular beam epitaxy ...
... for Anticipated VentriPoint Diagnostic System Launch, Alpha ... SEATTLE, Aug. 29 VentriPoint Diagnostics,(TSX: VPT) ... discussion and,analysis (MD&A), as well as its unaudited ... 2008, with the Canadian Securities Administrators,through the SEDAR ...
Cached Biology Technology:Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference 2'Racetrack' for fast electrons in semiconductor structures 2VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008 2
(Date:7/21/2014)... seriousness of disease often results from the strength of ... down that response, rather than attacking the virus, might ... Juliet Morrison of the University of Washington, Seattle. She ... in doing just that for the H7N9 influenza, and ... potential therapeutics for this highly virulent strain. The research ...
(Date:7/21/2014)... between songbird species, investigators have found that migration routes ... The research, which is published in Ecology Letters ... the position of a bird and allow its long ... parents, hybrids exhibited increased variability in their migratory routes: ... others used the same routes as one parental group ...
(Date:7/21/2014)... traditional apple orchards, effective management practices rely ... manage competitive vegetation under the trees, and ... factors are further complicated in organic management ... producers need to meet the stringent soil ... the National Organic Program. University of Arkansas ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Organic apple orchards benefit from green compost applications 2
... American Dietetic Association has published an updated position paper ... calls on schools and communities to work together to ... to promote educational environments that help students learn and ... updated position paper, published in the August issue of ...
... have identified a genetic variant which increases susceptibility to ... as a genome-wide association (GWA) study. This is the ... technique in Africans and demonstrates that such studies are ... of genetic diversity. Over the past few years, ...
... Providing patients with chronic heart failure access to remote ... technology, reduces deaths and hospitalisations and may provide benefits ... are the conclusions of a new Cochrane Systematic Review ... of patients can reduce pressure on resources, particularly for ...
Cached Biology News:Schools, communities share responsibility for child nutrition 2Schools, communities share responsibility for child nutrition 3Genome study identifies genetic variant linked to TB susceptibility in Africans 2Genome study identifies genetic variant linked to TB susceptibility in Africans 3Health care using telephone and telemonitoring technology benefits heart failure patients 2
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... comes with a shutter (controlled via a TTL ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ... lamp provides peak-to-peak stability of less than 0.005% ...
... The NOVOstar is an exciting product for ... cell-based assays required the use of expensive ... for scientists in the assay development stage. ... for cell-based assays as well as any ...
... intactness and detects events that dissipate ... Benefits: Fast, simple, and ... and for assaying mitochondria intactness ... for the detection of changes in ...
Biology Products: